Our new state-of-the-art R&D Center in Evionnaz opens for business this October! This significant milestone marks the completion of a project that began in January 2023, and we are thrilled to welcome over 100 skilled specialists who will drive innovation in drug substance development. As we continue to grow, we are actively looking to expand our team. If you are passionate about chemistry and ready to contribute to cutting-edge research, we have exciting opportunities available for Chemistry Lab Assistants. Join us in shaping the future of pharmaceutical innovation! Join us in building the future of pharmaceutical R&D. We look forward to your application https://lnkd.in/dDrKn-mX #TalentAcquisition #RDCenter #PharmaceuticalInnovation #ChemistryCareers #JoinOurTeam --- Notre nouveau Centre de R&D à la pointe de la technologie à Evionnaz ouvrira ses portes en octobre ! Ce jalon important marque l'achèvement d'un projet lancé en janvier 2023, et nous sommes ravis d'accueillir plus de 100 spécialistes qualifiés qui contribueront à l'innovation dans le développement de substances pharmaceutiques. Alors que nous continuons de croître, nous cherchons activement à agrandir notre équipe. Si vous êtes passionné par la chimie et prêt à participer à la recherche de pointe, nous avons des opportunités passionnantes pour des Assistants de Laboratoire en Chimie. Rejoignez-nous pour façonner l'avenir de l'innovation pharmaceutique ! Rejoignez-nous pour bâtir l'avenir de la R&D pharmaceutique. Nous attendons avec impatience votre candidature https://lnkd.in/dDrKn-mX #TalentAcquisition #RDCenter #PharmaceuticalInnovation #ChemistryCareers #JoinOurTeam
Siegfried
Arzneimittelherstellung
Zofingen, Aargau 28.853 Follower:innen
Expect more
Info
Expect more with Siegfried as your preferred partner. Siegfried is a preferred manufacturing and service partner in the global pharmaceutical industry. Our company is looking back on more than 150 years of unmatched quality and combines both chemistry and pharmaceutics under one roof. We develop and manufacture active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings. Approximately 3600 dedicated employees in Switzerland, Germany, France, Spain, Malta, China and the USA establish innovative and integrated solutions for our customers that bring a significant added value.
- Website
-
http://www.siegfried.ch
Externer Link zu Siegfried
- Branche
- Arzneimittelherstellung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Zofingen, Aargau
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 1873
- Spezialgebiete
- Formulation Development, Analytical Development, Solid Dosage Forms, Parenterals (vials, ampoules, cartridges, syringes), Ophtalmics (liquids and semisolids), API, Active Pharmaceutical Ingredient, Exclusive Synthesis, High Potency, Intermediates, Sterile Filling, biologics finished dosage forms und spray drying
Orte
Beschäftigte von Siegfried
Updates
-
EGS Beteiligungen AG exercised its right to convert also the second of the two convertible bonds issued in December 2020 with a coupon of 1.15% and a nominal value of CHF 40m into shares of Siegfried Holding AG. EGS Beteiligungen AG will receive 48'054 shares and as a result will increase its stake in Siegfried from 6.2% to about 7.2% registered shares.
-
Today, Marcel Imwinkelried officially steps into the role of our new CEO. With nearly two decades of senior leadership experience in the pharma industry, Marcel brings a wealth of expertise and a forward-looking vision. Under his guidance, we will continue to build a leading CDMO and manufacture safe drugs for millions of patients worldwide.
-
Siegfried‘s new quality control lab in Minden conducts more than 15000 chemical tests a month. Its high-tech measurement devices work so precise they could detect a grain of salt in a bath tub. Read more: https://lnkd.in/dnwf23wz
-
Siegfried opens its new state-of-the-art quality control lab in Minden. The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant.
Siegfried opens new quality control lab in Minden - Siegfried
https://www.siegfried.ch
-
Meet us at the 23rd Annual Contracting & Outsourcing Conference & Tabletop Exhibition! Visit us on Septemeber 26 and 27 at table #97 to discuss our offering with our experts. Register to attend: https://lnkd.in/dT8qyR-B #Contracting #Outsourcing #Expertise #CDMO #Partnership
-
Join Michael Levis' speaker session at the Reaction Calorimetry User Forum to learn more about the importance of process safety in particle design. Register to attend: loris.serraino@mt.com #Expertise #CDMO #processsafety #particledesign
-
Siegfried's positive results were driven by continued high demand for our products and services, ongoing active portfolio optimization and a strong focus on operational excellence and efficiency at all manufacturing sites. Discover more: https://lnkd.in/d8uTrPfj #mediarelease #halfyearresults #continousgrowth
-
In the first half of 2024, Siegfried continued its journey of profitable growth. Significant progress has been made in the implementation of the corporate strategy EVOLVE which is geared towards long-term profitable growth in core areas and beyond. Read the media release: https://lnkd.in/dbkaRmh6 #growth #profitability #halfyearresults #mediarelease
Siegfried continues to grow and increases profitability - Siegfried
https://www.siegfried.ch
-
We are proud to see our Zofingen team continue to grow.
HR Professional with heart | Supporting the companies growth and inspiring employees to perform their best | HR Passionate | Talent Spotter | Outdoor Addict
I am thrilled to announce that our #strongestteam 🥇 at #Siegfried is growing 👏 On our Welcome Day we have onboarded 13 new colleagues. Once again, I would like to welcome you on board and wish you an amazing ride and a lot of success 🍀🚀 You want to join us? Check out our openings and hope to see you soon! https://lnkd.in/ekB2eEtf